Aspirin, other painkillers may not reduce colorectal cancer risk for everybody | Science News

Support Science Journalism

Science News is a nonprofit.

Support us by subscribing now.


News in Brief

Aspirin, other painkillers may not reduce colorectal cancer risk for everybody

Particular genetic variants might render drugs’ effect nil or negative

By
11:40am, March 17, 2015
baby aspirin

RAISING RISK  Painkillers like this baby aspirin have been associated with reducing the risk of colorectal cancer, yet they can actually boost the risk in rare cases, a new study finds.

Regular use of aspirin and NSAIDs —nonsteroidal anti-inflammatory drugs — seems to reduce colorectal cancer risk in population studies. Yet a new study finds that people who harbor one of two genetic variants seem to have a heightened risk of the cancer if they take aspirin or NSAIDs, drugs that include ibuprofen and naproxen.

About 4 percent of people in the study carried one of these two rare variants, which are located in the vicinity of the MGST1 gene on chromosome 12. In this analysis, which appears in the March 17 JAMA, an international research team also detected a third genetic variant, this one in the neighborhood of the IL16 gene on chromosome 15. People carrying that variant, about 9 percent of participants, seemed to gain no protection from the drugs. Both MGST1 and IL16 belong to families of genes that have been linked to

This article is only available to Science News subscribers. Already a subscriber? Log in now.
Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content